Brief: Medigene, Iricor, And University Of Montréal Expand Analyses Of Potentially Novel Cancer Antigens

Medigene AG

02/12/2021 06:33

Dec 2 (Reuters) - MEDIGENE AG  MDG1k.DE :
    * MEDIGENE, IRICOR, AND UNIVERSITY OF MONTRÉAL EXPAND
ANALYSES OF
POTENTIALLY NOVEL CANCER ANTIGENS
    * CEO - UNDER CONTRACT EXPANSION WITH UDEM, WE ARE NOW ABLE
TO
INVESTIGATE TSAS IN COMBINATION WITH FURTHER HLA VARIANTS

Source text for Eikon:  ID:nPexbP8Wla 
Further company coverage:  MDG1k.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))